Treatment of transient and short term insomnia
OwnerNeil B. Kaveyinventor
Life of this patent
Estimating the term…
Abstract
The invention is directed to a method for the treatment of a patient suffering from transient or short term insomnia. The claimed method comprises the administration of a compound selected from the group consisting of the pharmaceutically acceptable forms of doxepin, amitriptyline, trimipramine, trazodone and mixtures thereof in dosages ranging from about 0.5 to about 20.0 milligrams.
Claims31
A method for the treatment of a patient suffering from non-chronic insomnia of from one night to about three weeks in duration comprising administering to said patient a compound selected from the group consisting of the pharmaceutically acceptable forms of doxepin, amitriptyline, trimipramine, trazodone and mixtures thereof in a daily dosage ranging from about 0.5 to about 20 milligrams.
Dependencies are inferred from the claim text.